Neurocrine Biosciences (0K6R.L) Stock Price

Financial Performance

The revenue of Neurocrine Biosciences has seen a decline in the last quarter by -8.8% from the previous quarter and is down by -3% year over year. The gross profit has also followed a similar trend, decreasing by -8.9% from the previous quarter and -1.9% YoY. The operating income has significantly dropped by -83.4% QoQ and -84% YoY which is concerning as it indicates that the company's operating efficiency might be declining. The EBITDA ratio being at 0.04 shows that profitability needs improvement.

Stock Price

The current stock price stands at $136.13, experiencing a drop of -3.1% in the past month which suggests short-term bearishness in the market sentiment towards this stock. However, with its 200-day moving average standing at $114,15, it suggests a longer-term bullish trend for this stock relative to recent prices despite some volatility.The RSI value close to mid-range (45) does not indicate any extreme buying or selling pressure.

Alternative Data Signals

The web traffic for Neurocrine Biosciences has been on a downward trend with an estimated decrease of about -11.9%, month over month which could imply less interest among consumers or investors about the company's products or services recently.Job postings have increased by 11%, MoM indicating potential expansion plans.The business outlook reported by employees is positive but showing downward trends both MoM (-8%) and YoY (-15%). Social media following on both Twitter and Facebook have seen considerable growth in recent times which can suggest increasing brand awareness.

Conclusion

In conclusion, while there are some positive signs in the long-term stock price trend and social media following, the declining financial performance and web traffic, as well as mixed signals from employee outlook and job postings, indicate a neutral to slightly bearish view for Neurocrine Biosciences' stock.

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Neurocrine Biosciences (0K6R.L), currently trading at $136.1, will... Sign up to access price prediction.